Could we design the RCT as a non-inferiority trial at this situation? [Design Issues]

posted by ElMaestro  – Denmark, 2022-07-26 14:44 (1059 d 15:34 ago) – Posting: # 23178
Views: 4,144

Hi dennis001


❝ So, could we design the RCT as a non-inferiority trial?


Clearly a case for an NI trial one way or another.

❝ Moreover, how to defining the non-inferiority margin at the situation?


Clearly a case for a scientific advice where you need the authority's nod for margin and design before you kick off.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,676 registered users;
46 visitors (0 registered, 46 guests [including 12 identified bots]).
Forum time: 06:18 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5